Table 3 Outcomes by baseline urine-LAM status among patients not on anti-TB treatment at study entry (n = 468)
|  | All patients (n = 468) | LAM positive (n = 38) | LAM Negative/TB diagnosed (n = 111) | LAM Negative/No TB diagnosed (n = 319) | p-value |
|---|---|---|---|---|---|
Clinical outcome at three months | |||||
 Required hospitalization | 50 (10.7) | 10 (26.3) | 20 (18.0) | 20 (6.3) | < 0.001 |
 Hospital readmission | 4 (0.9) | 0 | 2 (1.8) | 2 (0.6) | 0.48 |
 Vital status | |||||
  Dead | 31 (6.6) | 11 (29.0) | 6 (5.4) | 14 (4.4) | < 0.001 |
  LTFU | 2 (0.4) | 0 | 0 | 2 (0.6) |  |
  Alive | 435 (93.0) | 27 (71.1) | 105 (94.6) | 303 (95.0) |  |
Clinical outcome at  six months | |||||
 Required hospitalization | 73 (15.6) | 16 (42.1) | 29 (26.1) | 28 (8.8) | < 0.001 |
 Hospital readmission | 6 (1.3) | 1 (2.6) | 3 (2.7) | 2 (0.6) | 0.14 |
 Vital status | |||||
  Dead | 44 (9.4) | 12 (31.6) | 11 (9.9) | 21 (6.6) | < 0.001 |
  LTFU | 2 (0.4) | 0 | 0 | 2 (0.6) |  |
  Alive | 422 (90.2) | 26 (68.4) | 100 (90.1) | 296 (92.8) |  |
Clinical outcome at one year | |||||
 Required hospitalization | 84 (18.0) | 17 (44.7) | 36 (32.4) | 31 (9.7) | < 0.001 |
 Median time to hospitalization (IQR), (median [IQR] in days)a | 39 (13–129) | 18 (4–118) | 74 (14–166) | 31 (14–149) | 0.39 |
 Hospital readmission | 10 (2.1) | 1 (2.6) | 5 (4.5) | 4 (1.3) | 0.10 |
 Vital status | |||||
  Dead | 57 (12.2) | 12 (31.6) | 17 (15.3) | 28 (8.8) | 0.002 |
  LTFU | 7 (1.5) | 0 | 1 (0.9) | 6 (1.9) |  |
  Alive | 404 (86.3) | 26 (68.4) | 93 (83.8) | 285 (89.3) |  |
 Median time to death (IQR), (median [IQR] in days)b | 74 (25–140) | 19 (8–65) | 124 (38–259) | 90 (27–160) | 0.002 |
 Died without starting TB treatment (among all patients) | 35 (7.5) | 5 (13.2) | 2 (1.8) | 28 (8.8) | 0.021 |